NUS Scientists Develop Dry Eye Cure with Plant Power: An Eye-Opening Biological Crossover
In a groundbreaking development, researchers at the National University of Singapore (NUS) have unveiled a novel treatment for dry eye disease, a condition affecting over 1.5 billion people worldwide. This innovative approach, inspired by the photosynthetic abilities of plants, offers a simple, effective, and non-invasive solution to a debilitating eye condition. The key to this discovery lies in the unique ability of plants to harness sunlight, and the team's clever manipulation of this process to restore the eye's natural healing mechanisms.
Dry eye disease, characterized by corneal scarring, chronic pain, and blurred vision, has long been a significant health concern. Current treatments, such as cyclosporine A (Restasis®) and lifitegrast (Xiidra®), target inflammation but come with high costs and adverse side effects, limiting their long-term use. The NUS team, led by Associate Professor David Leong Tai Wei, has taken a fundamentally different approach by transplanting functional plant-derived photosynthetic machinery into corneal cells, enabling them to produce a crucial molecule, Nicotinamide Adenine Dinucleotide Phosphate (NADPH), independently.
The core innovation lies in the development of LEAF (Light-reaction Enriched thylAkoid NADPH-Foundry), a nanosized, structurally preserved version of the thylakoid grana, the light-reactions machinery of photosynthesis. By stripping away the part of the chloroplasts that consumes NADPH while keeping the thylakoids intact, the team created a dedicated NADPH factory. This factory, derived from spinach leaves, produces about 20% more NADPH compared to unpackaged thylakoids, and is small enough to be readily absorbed by cells.
In laboratory tests, LEAF restored NADPH levels within 30 minutes of light exposure, suppressed ROS (reactive oxygen species), and pivoted immune cells in the cornea from a pro-inflammatory to an anti-inflammatory state. When tested directly in tear samples from dry eye disease patients, LEAF increased NADPH levels roughly 20-fold and reduced hydrogen peroxide, a key cell-damaging oxidant, by more than 95%.
The team's first preclinical trial, conducted in collaboration with ophthalmologists from Eye Centre of Second Affiliated Hospital, Zhejiang University, demonstrated that LEAF administered as eye drops under ambient indoor lighting reversed corneal damage to near-healthy levels within five days, outperforming Restasis®. Safety assessments over two months showed no adverse effects, and the team plans to conduct clinical trials to further validate the technology.
The implications of this discovery are far-reaching. As oxidative stress underpins a wide range of inflammatory conditions beyond dry eye disease, the team sees potential for LEAF-based approaches wherever the body's antioxidant defences are overwhelmed, particularly in tissues naturally accessible to visible light such as the retina, skin, and underlying skeletal muscles. They are also developing new strategies to produce therapeutically useful photosynthesised molecules in internal organs without the need for visible light penetration.
Personally, I find this development particularly fascinating as it raises the intriguing question of whether mammals can also acquire some limited form of photosynthesis. The NUS team's work not only offers a potential cure for dry eye disease but also opens up new avenues for treating various inflammatory conditions. As we continue to explore the intersection of biology and technology, this discovery serves as a reminder of the incredible potential that lies within the natural world, and the power of human ingenuity to harness and manipulate it for the betterment of health and well-being.
In my opinion, this breakthrough is a testament to the importance of interdisciplinary research and the power of nature-inspired innovation. As we move forward, it will be fascinating to see how this technology develops and how it can be applied to other areas of medicine and beyond. One thing that immediately stands out is the potential for LEAF to revolutionize the treatment of various inflammatory conditions, and the team's commitment to exploring new strategies and applications is truly inspiring.
